SIRO Clinpharm Pvt Ltd

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  3. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
  4. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  5. Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

SIRO Clinpharm appoints chief executive

Takes responsibility for expanding business across the US, Europe and Asia
Regulatory

SIRO Clinpharm expands its presence in Asia

Launches operations in Malaysia
Regulatory

SIRO Clinpharm seeks Asia Pacific growth with DreamCIS pact

Mumbai-based contract research organisation SIRO Clinpharm has formed an alliance with DreamCIS, a CRO based in Seoul, South Korea in order to build its business in the Asia Pacific region.
Subscribe now